古汉医药集团股份公司 第十届董事会临时会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 古汉医药集团股份公司（以下简称"公司"）第十届董事会临时会议通知于2025年12月25日通过电子邮件 的方式发出。会议于2025年12月30日以通讯表决方式召开。会议应出席董事7人，实际参加表决董事7 人。会议的召开、表决程序符合《公司法》及《公司章程》的规定。形成如下决议： 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000590 证券简称：古汉医药 公告编号：2025-063 本议案尚需提交股东会审议，关联股东湖南赛乐仙需回避表决。 详见同日刊载于《中国证券报》《证券时报》《上海证券报》和巨潮资讯网 （http://www.cninfo.com.cn）上的《关于2026年度日常关联交易预计的公告》（2025-064）。 二、通过《关于全资子公司股权内部划转的议案》； 为更好地发挥公司下属子公司之间的协同效应，优化资源配置，结合公司战略规划，董事会同意公司将 其持有的广东先通药业有限公司100%股权无偿划转至公司全资子公司古汉中药有限公司。 表 ...

证券代码：000978 证券简称：桂林旅游 公告编号：2025-060 桂林旅游股份有限公司第七届董事会 2025年第十次会议决议公告 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 桂林旅游股份有限公司（以下简称"公司"）第七届董事会2025年第十次会议通知于2025年12月17日以书 面或电子文件的方式发给各位董事。会议于2025年12月23日以通讯表决的方式召开。 本次董事会会议应出席董事9人，实际出席董事9人（其中：委托出席的董事人数0人）。会议的召开符 合《公司法》和《公司章程》的有关规定。 二、董事会会议审议情况 会议逐项审议通过了关于补选公司董事会专门委员会委员的议案。 公司董事会同意补选张向荣董事为公司董事会战略委员会委员及审计委员会委员，表决情况如下： （1）张向荣董事为公司董事会战略委员会委员 表决情况：9票同意，0票反对，0票弃权。 （2）张向荣董事为公司董事会审计委员会委员 表决情况：9票同意，0票反对，0票弃权。 本次补选完成后，公司董事会战略委员会及审计委员会 ...

Group 1 - The company, Qitian Microelectronics, announced the establishment of a wholly-owned subsidiary, Shenzhen Junshenghe Trading Co., Ltd., with an investment of 5 million RMB, aimed at enhancing business development and competitiveness [2][3] - The subsidiary will engage in various activities including import and export of goods and technology, domestic trade, and software services, aligning with the company's strategic planning [3] - Qitian Microelectronics primarily focuses on the R&D, design, production, and sales of LCD and touch products, including monochrome and color LCD modules and capacitive touch screens [3] Group 2 - The company approved a proposal to postpone the completion dates for its fundraising projects, including the electronic paper module production line, R&D center construction, and Shenzhen industrial base, now set to December 31, 2027 [4][5] - The delay is attributed to the complexity of land transfer processes and the need to optimize factory layouts for smart production standards, while ensuring the feasibility and necessity of the projects remain unchanged [7] - The company asserts that the postponement will not adversely affect current operations and aligns with long-term strategic goals [7]

根据陕西康惠制药股份有限公司（以下简称"公司"）战略规划及经营发展需要，公司于2025年12月10日 召开第六届董事会第五次会议，审议通过《关于变更公司经营范围并修订〈公司章程〉的议案》，现将 有关情况公告如下： 一、变更经营范围情况 公司拟在现有经营范围基础上，同时结合市场监督管理部门对公司经营范围规范表述的要求，将公司经 营范围由"片剂、胶囊剂、颗粒剂、口服液、酒剂、茶剂、合剂、洗剂、搽剂、酊剂、膏药、软膏药的 生产，销售自产产品；中药前提取处理:医药化工技术的开发、转让及咨询服务；企业自产产品的运 输、配送。"变更为："许可项目：药品生产、药品批发、药品零售；药品委托生产。一般项目：技术开 发、技术咨询、技术交流、技术转让、技术推广、技术服务、计算机系统服务、数据处理和存储支持服 务、信息系统运行维护服务、机械设备销售、机械电气设备销售、计算机及通讯设备租赁、计算机软硬 件及辅助设备零售、计算机软硬件及辅助设备批发、销售代理；特殊医学用途配方食品销售；食品销售 （仅销售预包装食品）；食品互联网销售（仅销售预包装食品）；保健食品（预包装）销售；化妆品批 发；化妆品零售。" 证券代码：603139 证券简称 ...

11月26日晚间，招商基金公告称，王颖自11月27日起任招商基金董事长、法定代表人。 招商基金未来将从三大战略框架方向着力：一是以主动管理业务和被动指数业务双轮驱动，不断强化公 司核心业务布局。二是持续围绕客户导向化经营、投研平台化深耕、经营数智化赋能、管理科学化升级 四大战略迭代优化。三是聚焦党建、内控、机制改革、人才队伍建设、股东联动、企业文化等六大机 制，为实现公司战略目标提供保障。 在与股东方的互动方面，招商基金表示，未来将进一步融入股东发展战略，更好立足深度研究共享、优 质资产组织和产品创设、创新试验田三个定位，夯实与股东的战略协同基础，持续构建战略联动，做好 客户投资的产品供应方、投行与金融市场的资金方、投研与资产配置的能力贡献者。 公开资料显示，招商基金成立于2002年，其第一大股东为招商银行，持股比例达55%，第二大股东招商 证券持股45%。 王颖在招商银行任职多年，1997年1月加入招商银行后，历任招商银行北京分行行长助理、副行长，天 津分行行长，深圳分行行长，招商银行行长助理。2023年11月起任招商银行副行长。招商银行为招商基 金第一大股东，截至今年三季度末，招商基金总管理规模超过900 ...

Core Viewpoint - Meihua (603538.SH) announced a capital increase of 297 million RMB for its wholly-owned subsidiary Xuancheng Meihua to enhance production scale and optimize its industrial structure, promoting high-quality development [1] Group 1: Capital Increase Details - The capital increase will raise Xuancheng Meihua's registered capital from 196 million RMB to 384 million RMB at a price of 1.58 RMB per registered capital [1] - After the capital increase, the company will hold a 51% stake in Xuancheng Meihua, while Anhui Meihua will hold 49% [1] Group 2: Strategic Implications - The capital increase aligns with the company's overall strategic planning and aims to expand the operational scale of Xuancheng Meihua [1] - The decision to waive the preemptive subscription rights was made based on a comprehensive assessment of business strategy, capital efficiency, and potential investment needs, ensuring no harm to the interests of the company or its shareholders, especially minority shareholders [1] - Xuancheng Meihua will remain a controlled subsidiary within the company's consolidated financial statements, with no changes to the scope of consolidation [1]

Core Viewpoint - The company, 瑞玛精密, has approved the establishment of a wholly-owned subsidiary, 广州市信征汽车舒适系统有限公司, to support its business development and align with its long-term strategic planning [2] Summary by Relevant Sections Company Announcement - On November 10, 瑞玛精密 announced the approval of a proposal to establish a wholly-owned subsidiary [2] - The new subsidiary will be named 广州市信征汽车舒适系统有限公司 with a registered capital of 10 million yuan [2] Business Scope - The business scope of the new subsidiary includes: - Manufacturing of automotive parts and components - Research and development of automotive parts - Wholesale of automotive parts - Sales of new energy vehicle battery swap facilities - Sales of new energy vehicle electrical accessories - Manufacturing and sales of automotive decorative products - Retail of automotive parts - Information consulting services [2] Strategic Intent - The establishment of the subsidiary is aimed at meeting the operational needs of the company and is consistent with its long-term strategic goals [2] - The company asserts that this move will not have a significant adverse impact on its financial and operational status and will not harm the interests of the company and its shareholders [2]

Core Points - The article outlines the establishment and operational rules of the Strategic Committee of Zhuhai Hengji Daxin International Chemical Storage Co., Ltd, aimed at enhancing the company's core competitiveness and improving investment decision-making processes [3][4][8] Group 1: General Provisions - The Strategic Committee is a specialized working body established by the Board of Directors to conduct feasibility studies on long-term strategic planning and major strategic investments, providing recommendations to the Board [3][4] - The committee consists of three directors, including at least one independent director, and is chaired by the Chairman of the Board [3][4] Group 2: Responsibilities and Authority - The main responsibilities of the Strategic Committee include researching and proposing suggestions for the company's long-term strategic planning, major investment financing plans, and significant capital operations [4][5] - The committee is responsible for reviewing the implementation of these matters and any other issues authorized by the Board [4][5] Group 3: Working Procedures - An Investment Review Group is established under the Strategic Committee, led by the General Manager, to prepare for decision-making by providing relevant materials [5][6] - The Strategic Committee holds regular meetings at least once a year and can convene temporary meetings as needed, ensuring that all members can communicate effectively [6][7] Group 4: Meeting Rules - Meetings require the presence of at least two-thirds of the committee members to be valid, and decisions must be approved by a majority [7][8] - The committee can invite external professionals for advice, with costs covered by the company [7][8]

Core Viewpoint - Midea Group has appointed Wang Jianguo as the Executive President, marking the first time the position has been established since Fang Hongbo became Chairman. This move aligns with the company's strategic planning needs [1] Group 1: Management Changes - Wang Jianguo has been appointed as the Executive President, stepping down from his previous role as Vice President [1] - This is the first establishment of the Executive President position under Fang Hongbo's leadership as Chairman [1] Group 2: Strategic Planning - The creation of the Executive President role is intended to assist the Group President in handling relevant tasks, reflecting the company's strategic planning requirements [1] - Fang Hongbo has previously indicated a retirement plan at the age of 60, with a goal to achieve 500 billion yuan in revenue before his retirement [1] Group 3: Market Reactions - The announcement of Fang Hongbo's impending retirement has garnered attention within the industry, although Midea has not commented on this matter [1]

Core Points - The document outlines the working rules of the Strategic Committee of Hubei Hendi Pharmaceutical Co., Ltd. to enhance the company's core competitiveness and improve decision-making processes [1][2] - The committee is responsible for researching and proposing suggestions on the company's long-term development strategy and major investment decisions [1][2] Organizational Structure - The committee consists of three directors, including at least one independent director [2] - Committee members are nominated by the chairman, more than half of the independent directors, or one-third of all directors, and elected by the board [2] - The committee has a chairperson, typically the chairman of the board, who is responsible for leading the committee's work [2] Responsibilities of the Committee - The main responsibilities include researching and proposing suggestions on the company's long-term strategic planning, major investment decisions, significant financing plans, and other major matters affecting the company's development [3][4] - The committee is also tasked with checking the implementation of these matters and reporting to the board [4] Meeting Procedures - The committee must hold at least one meeting annually, with additional meetings called as needed [6] - Meetings require the presence of at least two-thirds of the committee members to be valid, and decisions are made by a majority vote [6][9] - The chairperson leads the meetings and is responsible for reporting to the board [7][9] Documentation and Reporting - The committee must maintain meeting records, which include members' opinions and decisions made during the meetings [9] - Reports from the committee must be submitted to the board in written form [9][10] Amendments and Compliance - The rules are subject to amendments based on national laws and regulations, and the board is responsible for interpreting these rules [10][10]